Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Thomas, Joseph T ^a   Muller, P ^b   Wilkinson, C ^b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b NONE

Author keywords

Excitatory amino acid antagonists * administration dosage ; Infant, newborn; Jaundice, neonatal etiology; * prevention control ; Phenobarbital * administration dosage ; Prenatal care * methods

Indexed keywords

ERYTHROCYTE ANTIBODY; PHENOBARBITAL;

EXCHANGE BLOOD TRANSFUSION; HUMAN; IMMUNIZATION; NEWBORN JAUNDICE; PHOTOTHERAPY; PREGNANCY; PRENATAL CARE; REVIEW;

EID: 44949104201     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005541.pub2     Document Type: Review

References (15)

1. Ramboer 1969 *Ramboer C, Thompson RPH, Williams R. Controlled trials of phenobarbitone therapy in neonatal jaundice. Lancet 1969;1(7602):966-8.
2. Ramboer C, Thompson RPH, Williams R. Treatment of neonatal jaundice with phenobarbitone. British Society of Gastroenterology 1969;1:414.
3. Towers 1977 Towers SH, McMullin GP. Controlled trial of antenatal barbiturates in rhesus haemolytic disease. Archives of Disease in Childhood 1977;52(4):324-5.
4. Valaes 1970 Valaes T, Kipouros K, Petmezaki S, Solman M, Doxiadis SA. Effectiveness and safety of prenatal phenobarbital for the prevention of neonatal jaundice. Pediatric Research 1980;14(8):947-52.
5. *Valaes T, Petmezaki S, Doxiadis SA. Effect on neonatal hyperbilirubinemia of phenobarbital during pregnancy or after birth: practical value of the treatment in a population with high risk of unexplained severe neonatal jaundice. Birth Defects 1970;6:46-54.
6. AAP 2002 AAP, ACOG. Guidelines for perinatal care. Fifth. USA: AAP and ACOG, 2002.
7. Gabbe 2002 Gabbe SG, Neibyl JR, Simpson JL. Alloimunization in pregnancy. Obstetrics. Normal and problem pregnancies. Fourth. New York, USA: Churchill Livingstonw, 2002:893-930.
8. Katzung 1998 Katzung BG. Basic and clinical pharmacology. Seventh. USA: Appleton and Lange, 1998:Drug Biotransformation 50-54.
9. Kawasaki 1982 Kawasaki H, Murawaki Y, Kimura N, Hirayama C. Effects of phenobarbital on unconjugated bilirubin clearance, gamma-glutamyltranspeptidase and urinary d-glucaric acid in patients with Gilbert's syndrome. Hepatogastroenterology 1982;29(6):252-5.
10. Price 1986 Price DE, Mehta A, Park BK, Hay A, Feely MP. The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction. British Journal of Clinical Pharmacology 1986;22(6): 744-7.
11. Rayburn 1998 Rayburn W, Donn S, Piehl E, Compton A. Antenatal phenobarbital and bilirubin metabolism in the very low birth weight infant. American Journal of Obstetrics and Gynecology 1988;159(6):1491-3.
12. Thomas 1976 Thomas CR. Routine phenobarbital for prevention of neonatal hyperbilirubinemia. Obstetrics & Gynecology 1976;47(3):304-8.
13. Trevett 2004 Trevett T, Dorman K, Lamvu G, Moise K. Does antenatal maternal administration of phenobarbital prevent exchange transfusion in neonates with alloimmune hemolytic disease?. Society of Maternal-Fetal Medicine 24th Annual Clinical Meeting; 2004 February 2-7; New Orleans, Louisiana, USA. 2004:565.
14. Trevett 2005 Trevett TN Jr, Dorman K, Lamvu G, Moise KJ Jr. Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn. American Journal of Obstetrics and Gynecology 2005;192(2):478-82.
15. Wennberg 1978 Wennberg RP, Depp R, Heinrichs WL. Indications for early exchange transfusion in patients with erythroblastosis fetalis. Journal of Pediatrics 1978;92(5):789-92.